Literature DB >> 15507658

Vpr and Vpu are important for efficient human immunodeficiency virus type 1 replication and CD4+ T-cell depletion in human lymphoid tissue ex vivo.

Elke Rücker1, Jean-Charles Grivel, Jan Münch, Frank Kirchhoff, Leonid Margolis.   

Abstract

The relevance of the accessory vpr, vpu, and nef genes for human immunodeficiency virus type 1 (HIV-1) replication in human lymphoid tissue (HLT), the major site of viral replication in vivo, is largely unknown. Here, we show that an individual deletion of nef, vpr, or vpu significantly decreases HIV-1 replication and prevents CD4+ T-cell depletion in ex vivo HLT. However, only combined defects in all three accessory genes entirely disrupt the replicative capacity of HIV-1. Our results demonstrate that nef, vpr, and vpu are all essential for efficient viral spread in HLT, suggesting an important role in AIDS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507658      PMCID: PMC525056          DOI: 10.1128/JVI.78.22.12689-12693.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Human immunodeficiency virus vpr product is a virion-associated regulatory protein.

Authors:  E A Cohen; G Dehni; J G Sodroski; W A Haseltine
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

2.  Origin of vpx in lentiviruses.

Authors:  M Tristem; C Marshall; A Karpas; J Petrik; F Hill
Journal:  Nature       Date:  1990-09-27       Impact factor: 49.962

3.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

4.  Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein.

Authors:  K Strebel; T Klimkait; F Maldarelli; M A Martin
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo.

Authors:  S Glushakova; J C Grivel; K Suryanarayana; P Meylan; J D Lifson; R Desrosiers; L Margolis
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection.

Authors:  L Alexander; E Weiskopf; T C Greenough; N C Gaddis; M R Auerbach; M H Malim; S J O'Brien; B D Walker; J L Sullivan; R C Desrosiers
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production.

Authors:  Vasundhara Varthakavi; Rita M Smith; Stephan P Bour; Klaus Strebel; Paul Spearman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

8.  Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel.

Authors:  Kate Hsu; Jegatheesan Seharaseyon; Peihong Dong; Stephan Bour; Eduardo Marbán
Journal:  Mol Cell       Date:  2004-04-23       Impact factor: 17.970

9.  HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.

Authors:  Mariana Marin; Kristine M Rose; Susan L Kozak; David Kabat
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

10.  The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.

Authors:  Ann M Sheehy; Nathan C Gaddis; Michael H Malim
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

View more
  28 in total

1.  Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.

Authors:  Steffen Wildum; Michael Schindler; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  HIV-1-Mediated Downmodulation of HLA-C Impacts Target Cell Recognition and Antiviral Activity of NK Cells.

Authors:  Christian Körner; Camille R Simoneau; Philipp Schommers; Mitchell Granoff; Maja Ziegler; Angelique Hölzemer; Sebastian Lunemann; Janet Chukwukelu; Björn Corleis; Vivek Naranbhai; Douglas S Kwon; Eileen P Scully; Stephanie Jost; Frank Kirchhoff; Mary Carrington; Marcus Altfeld
Journal:  Cell Host Microbe       Date:  2017-07-12       Impact factor: 21.023

3.  Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation.

Authors:  Frederic Bibollet-Ruche; Anke Heigele; Brandon F Keele; Juliet L Easlick; Julie M Decker; Jun Takehisa; Gerald Learn; Paul M Sharp; Beatrice H Hahn; Frank Kirchhoff
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

4.  Primary sooty mangabey simian immunodeficiency virus and human immunodeficiency virus type 2 nef alleles modulate cell surface expression of various human receptors and enhance viral infectivity and replication.

Authors:  Jan Münch; Michael Schindler; Steffen Wildum; Elke Rücker; Nicola Bailer; Volker Knoop; Francis J Novembre; Frank Kirchhoff
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 inhibits DNA damage-triggered apoptosis by a Nef-independent mechanism.

Authors:  Michael Schindler; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees.

Authors:  Jun Takehisa; Matthias H Kraus; Julie M Decker; Yingying Li; Brandon F Keele; Fréderic Bibollet-Ruche; Kenneth P Zammit; Zhiping Weng; Mario L Santiago; Shadrack Kamenya; Michael L Wilson; Anne E Pusey; Elizabeth Bailes; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

7.  The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death.

Authors:  Syed Mohammad Moin; Milena Panteva; Shahid Jameel
Journal:  J Biol Chem       Date:  2007-05-08       Impact factor: 5.157

8.  Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures.

Authors:  Silvia Geuenich; Lars Kaderali; Ina Allespach; Serkan Sertel; Oliver T Keppler
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

9.  Early Vertebrate Evolution of the Host Restriction Factor Tetherin.

Authors:  Elena Heusinger; Silvia F Kluge; Frank Kirchhoff; Daniel Sauter
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

10.  Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue.

Authors:  Michael Schindler; Devi Rajan; Carina Banning; Peter Wimmer; Herwig Koppensteiner; Alicja Iwanski; Anke Specht; Daniel Sauter; Thomas Dobner; Frank Kirchhoff
Journal:  Retrovirology       Date:  2010-01-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.